Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velafermin for Prevention of Oral Mucositis in HSCT
NCT00104065Phase 2Completed
- Sponsor
- CuraGen Corporation
- Start
- Jan 2005
- Primary completion
- Dec 2005
- Modality
- Hormones & Growth Factors
- Countries
- 1
01
Overview
A Phase 2 trial of velafermin in oral mucositis (OM), sponsored by CuraGen Corporation. Started Jan 2005; status: completed.
02
Drugs
velafermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00104065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104065.